KRMD EBITDA
-$1.02MTTM · USD
Period ending:
KRMD FY EBITDAUSD
$4.34M-$10.09M
2000-02-292025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
KRMD ebitda history
Earnings before interest, taxes, depreciation, and amortization. The available annual fiscal periods series contains 27 observations from Feb 29, 2000 to Dec 31, 2025.
| Period ending | EBITDA (USD) |
|---|---|
| -1,805,536 | |
| -5,175,267 | |
| -8,903,192 | |
| -10,088,023 | |
| -5,901,311 | |
| 1,611,023 | |
| 4,341,591 | |
| 2,372,802 | |
| 1,877,733 | |
| -474,202 | |
| 1,417,548 | |
| 1,358,923 | |
| 1,240,630 | |
| 1,253,375 | |
| 1,416,707 | |
| 1,295,286 | |
| 774,763 | |
| 855,894 | |
| 261,707 | |
| 38,290 | |
| -9,164 | |
| -277,535 | |
| -165,091 | |
| -171,120 | |
| -289,421 | |
| -17,380 | |
| -149,542 |
Compare ebitda
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) ebitda
- Bridgebio Pharma Inc (BBIO) ebitda
- Brightspring Health Services Inc (BTSG) ebitda
- Madrigal Pharmaceuticals Inc (MDGL) ebitda
- Ensign Group Inc (ENSG) ebitda
- Glaukos Corp (GKOS) ebitda
- Vaxcyte Inc (PCVX) ebitda
- Krystal Biotech Inc (KRYS) ebitda
All KRMD financial metrics · KRMD stock overview · How to interpret financial metrics
